EP3601283
Samrunnið imídasó-píperidín-JAK-hindra-efnasamband
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
30.4.2018EP published:
29.12.2021EP application number:
18724754.9
EP translation filed:
24.2.2022Grant published:
15.3.2022EPO information:
European Patent Register
Max expiry date:
29.4.2038Expiry date:
29.4.2024
Title in English:
FUSED IMIDAZO-PIPERIDINE JAK INHIBITOR COMPOUNDLanguage of the patent:
English
Timeline
Today
30.4.2018EP application
29.12.2021EP Publication
24.2.2022Translation submitted
15.3.2022Registration published
29.4.2024Expires
Owner
Name:
Theravance Biopharma R&D IP, LLCAddress:
901 Gateway Boulevard, South San Francisco, CA 94080, US
Inventor
Name:
FATHEREE, Paul R.Address:
San Francisco, California 94107, US
Name:
JIANG, LanAddress:
Foster City, California 94404, US
Name:
MCKINNELL, Robert MurrayAddress:
Millbrae, California 94030, US
Name:
THALLADI, Venkat R.Address:
Foster City, California 94404, US
Name:
ZHANG, HaoAddress:
Foster City, California 94404, US
Name:
DABROS, MartaAddress:
Foster City, California 94404, US
Name:
NZEREM, JerryAddress:
South San Francisco, California 94080, US
Name:
BENJAMIN, NoahAddress:
San Francisco, California 94122, US
Name:
KLEINSCHEK, Melanie A.Address:
South San Francisco, California 94080, US
Name:
CRATER, Glenn D.Address:
Raleigh, North Carolina 27612, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201762492574 PDate:
1.5.2017Country:
US
Classification
Categories:
C07D 471/04, A61K 31/437, A61P 11/00, A61P 17/00, A61P 27/02
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 31.3.2022
Expires: 29.4.2023
Payer: Patice ehf.
Number: 6
Paid: 31.3.2023
Expires: 29.4.2024
Payer: Árnason Faktor ehf.